secwatch.observer — SEC 8-K summary
======================================

Issuer:     Picard Medical, Inc. (PMI)
CIK:        0002030617
Form:       8-K
Filed at:   2026-07-27T13:12:15+00:00
Accession:  0001437749-26-024465
Event type: regulatory
Sentiment:  neutral
Materiality: 0.60
Item codes: 3.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NYSE American accepts Picard Medical's compliance plan; listing continues through Nov 2027
--------------------------------------------------------------------------------

- NYSE American accepted compliance plan under Sections 1003(a)(i) and (ii) due to low equity and losses.
- Company may continue listing on NYSE American under symbol PMI while executing the plan.
- Compliance period through November 8, 2027, subject to quarterly review by NYSE American.
- Company must achieve milestones set forth in the compliance plan to regain full compliance.
- Interim CEO Richard Fang cites progress on Emperor Total Artificial Heart and financial position.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2030617/000143774926024465/0001437749-26-024465-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2030617/000143774926024465/pmi20260722_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-26-024465

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer